REQUEST A DEMO
Total
USD $0.00
Search more companies

Tavanta Therapeutics Hungary Zrt. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Tavanta Therapeutics Hungary Zrt. Profile Updated: September 26, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Tavanta Therapeutics Hungary Zrt. is an enterprise in Hungary, with the main office in Budapest. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences sector. It was established on December 21, 2006. 15 (2023) employees currently work for Tavanta Therapeutics Hungary Zrt.. There was a net sales revenue drop of 58.26% reported in Tavanta Therapeutics Hungary Zrt.’s latest financial highlights for 2024. Its total assets grew by 39.15% over the same period. The net profit margin of Tavanta Therapeutics Hungary Zrt. increased by 1.45% in 2024.

Headquarters
Madarasz Viktor utca 47-49.
Budapest; Budapest; Postal Code: 1138

Contact Details: Purchase the Tavanta Therapeutics Hungary Zrt. report to view the information.

Website: http://www.nangenex.com

Basic Information
Total Employees:
Purchase the Tavanta Therapeutics Hungary Zrt. report to view the information.
Registered Capital:
Purchase the Tavanta Therapeutics Hungary Zrt. report to view the information.
Financial Auditors:
Purchase the Tavanta Therapeutics Hungary Zrt. report to view the information.
Incorporation Date:
December 21, 2006
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Tavanta Therapeutics Hungary Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-58.26%
Total operating revenue
-57.19%
Operating profit (EBIT)
-76.98%
EBITDA
-54.89%
Net Profit (Loss) for the Period
-48.15%
Total Assets
39.15%
Total Equity
57.27%
Operating Profit Margin (ROS)
-4.17%
Net Profit Margin
1.45%
Return on Equity (ROE)
-26.25%
Quick Ratio
1.73%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?